Study #2023-0568
ETHAN: A phase II study comparing different Endocrine Therapies for male breast cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Tamoxifen, Anastrozole, Degarelix, Abemaciclib
Description
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer. The drugs used in this study are: * Tamoxifen * Anastrozole * Degarelix * Abemaciclib
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma
Study phase:
Phase II
Physician name:
Jasmine Sukumar
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-866-254-1401
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.